the statement of comprehensive income when the real estate project has been completed and transferred to the customers after completion of the payment. Despite the disposal of assets, the Company has

December 31 , 2018 , the Comprehensive Income Statement and the auditor’s report, which are audited by the auditor for the year ended December 31, 2018. Agenda 5 To approve the annual dividend payment and

. Return on Equity and Return on Asset are 20.8% and 4.2%, respectively. In addition, the Board of Directors’ meeting has approved the final dividend payment for the fiscal year ended February 28, 2019, at

peak in Q1 2019 and then will be repaid over the rest of the year. There was no dividend payment in 1Q 2018. In line with our current strategy of regular dividends 1Q 2019 will have a payout of 0.12THB

the real estate project has been completed and transferred to the customers after completion of the payment. Despite the sales of assets in the previous year there are remaining backlog and inventories

in BS Myco Biotech Company Limited from the Sellers is at Baht 50 million after this transaction will result in the BS Myco Biotech being a subsidiary of the Company. 5.2 Payment The Company paid the

for the payment of assets X 100 Paid-up shares of the company Not applicable since the Company does not issue any securities as the consideration 6. Detail of Assets Acquired 6.1 General Information 6.1

major changes in the shareholders' equity during the period were (1) increased paid-up capital from THB 225.0 Mn to THB 300.0 in preparation for the initial public offering (2) payment of shareholder

month period of 2019, with the amount of 17.65 million baht while the Company also had dividend payment amounting to 25.20 million baht in May 2019. Please be informed accordingly Yours sincerely Miss

retained earnings as a result of the recent dividend payment in May. Financial Ratio Financial Ratio As of June 30, 2019 Liquidity Ratio (times) 27.80 Debt to Equity Ratio (times) 0.04 Return on Equity - ROE